Critical appraisal of paroxetine for the treatment of vasomotor symptoms
Dana G Carroll,1,2 Katelin M Lisenby,1,2 Tracy L Carter3 1Department of Pharmacy Practice, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA; 2Department of Family Medicine, College of Community Health Sciences, University of Alabama, University Medical Center, Tuscaloosa, AL, USA; 3De...
Saved in:
Main Authors: | Carroll DG (Author), Lisenby KM (Author), Carter TL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms
by: David PS, et al.
Published: (2022) -
Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
by: Uml, et al.
Published: (2012) -
Breakthroughs in women's health for treating vasomotor symptoms
by: Peng-Hui Wang, et al.
Published: (2024) -
The cause of vasomotor symptoms: Resonance phenomena in the vascular bed
by: Keiko Uohashi
Published: (2022) -
Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms
by: Savita Rani Singhal, et al.
Published: (2016)